MedPath

Looking for a Blood Epigenetic Signature to Predict Female Infertility

Recruiting
Conditions
Female Infertility
Registration Number
NCT06098495
Lead Sponsor
Università Vita-Salute San Raffaele
Brief Summary

The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
1456
Inclusion Criteria
  • 18< age <43, Infertile woman undergoing ART, recurrent pregnancy loss
Exclusion Criteria
  • age < 18 or > 44, previous ovarian surgery, severe male factor infertility

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
impact of exogenous pro-inflammatory factors3 years

on all the above cohorts will be investigated, via online questionnaire

differences of DNA methylationin the peripheral venous blood of new patients undergoing ART3 years

The specific epigenetic modification will be searched in the peripheral venous blood of two new cohorts of patients referred to PMA centres.

differences of DNA methylationin the peripheral venous blood of patients undergoing ART3 years

search for this methylation difference found in the granulosa cell sample, also in the peripheral venous blood of these same patients

differences of DNA methylation in granulosa cells of patients undergoing ART3 years

The epigenetic profile of DNA extracted from granulosa cells of patients undergoing ART (COHORT1) will be examined to identify position and region's differences of DNA methylation in pregnant women (fertile women) and in who does not get pregnant (infertile women)

differences of DNA methylationin the peripheral venous blood of women attempting to conceive naturally3 years

The specific epigenetic modification will be searched in the peripheral venous blood of women attempting to conceive naturally (COHORT2)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Università Vita Salute San Raffaele

🇮🇹

Milano, Italy

Università Vita Salute San Raffaele
🇮🇹Milano, Italy
Valeria Stella Vanni
Contact
+393476309895
vanni.valeria@hsr.it
Sara D'Alessandro
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.